miércoles, 5 de abril de 2023

FDA authorizes Gohibic (vilobelimab) injection for the treatment of COVID-19 | FDA

FDA authorizes Gohibic (vilobelimab) injection for the treatment of COVID-19 | FDA

No hay comentarios:

Publicar un comentario